Echocardiographic screening vs. symptomatic diagnosis for patent ductus arteriosus in preterms
Main Article Content
Keywords
Screening, Ductus arteriosusm, Preterm, Echocardiography
Abstract
Background: The persistence of ductus arteriosus, the aim of this study is to evaluate the possible benefit in the treatment for ductus closure when a early (less tan 72 hours of life) echocardiographic screening is done versus when the echocardiographic diagnosis is realized only in present of associated symptoms.
Methods: Preterm without malformation followed by two strategies: patent ductus arteriosus (PDA) screening or echocardiographic study on suspected PDA for symptoms (control group). We analized the ductus characteristics, the presence of pulmonary hypertension and the treatments for their closure. We analize the result in relation of the premature age as: late preterm (34 to 36 gestational age weeks), moderate (30 to 33) and extreme (< 30).
Results: There was no diference in the proportion of newborns diagnosed with PDA among the strategies (screening 18.6 % [101/543] vs 18.1 % [55/304], p = 0.92). In the control group, 53 % were diagnosed after 72 hours of life. There were no differences in realtion of the ductus characteristic among the groups. The closure treatment were similar in the two strategies among the moderate and late preterm, but was more aggressive in the control group in the extreme preterms.
Conclusion: The echocardiographic screening for PDA in extreme preterm newborns reduce the time to detect it, and allow to give less agressive treatment. We do not recommend their use in moderate o late preterm newborn.
References
Ruiz González MD, Gómez Guzmán E, Párraga Quiles MJ, Tejero MA, Guzmán Cabañas JM. Ductus arterioso persistente. Protocolos diagnóstico terapéuticos de la AEP: Neonatología. [Cap.] 36. [España]: Asociación Española de Pediatría; 2008. p. 353-61.
Golombek SG, Sola A, Baquero H, Borbonet D, Cabañas F, Fajardo C, et al. Primer consenso clínico de SIBEN: enfoque diagnóstico y terapéutico del ductus arterioso permeable en recién nacidos pretérmino. An Pediatr (Barc). 2008;69(5):454-81.
Kohsitseth A, Muangyod N, Nuntnarumit P. Perfusion index as a diagnostic tool for patent ductus arteriosus in preterm infants. Neonatology. 2013;104(4):250-4.
Alan S, Karadeniz C, Okulu E, Kılıc A, Erdeve O, Ucar T, et al. Management of patent ductus arteriosus in preterm infants: clinical judgment might be a fair option. J Matern Fetal Neonatal Med. 2013;26(18):1850-4.
DeMauro SB, Cohen MS, Ratcliffe SJ, Abbasi S, Schmidt B. Serial echocardiography in very preterm infants: a pilot randomized trial. Acta Paediatr. 2013; 102(11):1048-53.
O´Rourke DJ, El-Khuffash A, Moody C, Walsh K, Molloy EJ. Patent ductus arteriosus evaluation by serial echocardiography in preterm infants.Acta Paediatr. 2008;97(5):574-8.
Lago P, Salvadori S, Opocher F, Ricato S, Chiandetti L, Frigo AC. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants. Neonatology. 2014;105(1):46-54.
Lee A, Nestaas E, Liestøl K, Brunvand L, Lindemann R, Fugelseth D. Tissue doppler imaging in very preterm infants during the first 24 h of life: an observational study. Arch Dis Child Fetal Neonatal Ed. 2014; 99(1):F64-9.
Stoller JZ, Demauro SB, Dagle JM, Reese J. Current perspectives on pathobiology of the ductus arteriosus. J Clin Exp Cardiol. 2012;8(1).pii: S8-001. doi:10.4172/2155-9880.S8-001.
Lee CH, Chen HN, Tsao LY, Hsiao CC, Lee ML. Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants. Pediatr Neonatol. 2012;53(6):346-53.
Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Patent ductus arteriosus in preterm infants: do we have the right answers?. Biomed Res Int [Internet]. 2013;2013. [aprox. 15 p.]. Disponible en http://dx.doi.org/10.1155/2013/676192.
Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr. 1995;127(5):774-9.